Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB STRIDES PHARMA SCIENCE UNICHEM LAB/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 236.1 -1,455.3 - View Chart
P/BV x 1.4 3.3 43.3% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 UNICHEM LAB   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    UNICHEM LAB
Mar-23
STRIDES PHARMA SCIENCE
Mar-23
UNICHEM LAB/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs467392 119.1%   
Low Rs226263 85.8%   
Sales per share (Unadj.) Rs190.7408.5 46.7%  
Earnings per share (Unadj.) Rs-28.7-25.6 112.3%  
Cash flow per share (Unadj.) Rs-12.61.4 -921.8%  
Dividends per share (Unadj.) Rs01.50 0.0%  
Avg Dividend yield %00.5 0.0%  
Book value per share (Unadj.) Rs344.2242.8 141.7%  
Shares outstanding (eoy) m70.4190.30 78.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.80.8 226.3%   
Avg P/E ratio x-12.1-12.8 94.1%  
P/CF ratio (eoy) x-27.5239.6 -11.5%  
Price / Book Value ratio x1.01.4 74.6%  
Dividend payout %0-5.9 0.0%   
Avg Mkt Cap Rs m24,39629,603 82.4%   
No. of employees `000NANA-   
Total wages/salary Rs m3,5647,320 48.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m13,43036,884 36.4%  
Other income Rs m3851,352 28.5%   
Total revenues Rs m13,81538,236 36.1%   
Gross profit Rs m-841830 -101.4%  
Depreciation Rs m1,1342,433 46.6%   
Interest Rs m1732,611 6.6%   
Profit before tax Rs m-1,764-2,862 61.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m259-553 -46.8%   
Profit after tax Rs m-2,022-2,309 87.6%  
Gross profit margin %-6.32.2 -278.4%  
Effective tax rate %-14.719.3 -75.9%   
Net profit margin %-15.1-6.3 240.5%  
BALANCE SHEET DATA
Current assets Rs m15,88531,353 50.7%   
Current liabilities Rs m6,39629,902 21.4%   
Net working cap to sales %70.73.9 1,796.6%  
Current ratio x2.51.0 236.9%  
Inventory Days Days5171 72.0%  
Debtors Days Days1,600129 1,244.1%  
Net fixed assets Rs m15,91131,300 50.8%   
Share capital Rs m141903 15.6%   
"Free" reserves Rs m24,09221,025 114.6%   
Net worth Rs m24,23321,928 110.5%   
Long term debt Rs m63611,398 5.6%   
Total assets Rs m31,82963,734 49.9%  
Interest coverage x-9.2-0.1 9,574.0%   
Debt to equity ratio x00.5 5.1%  
Sales to assets ratio x0.40.6 72.9%   
Return on assets %-5.80.5 -1,224.3%  
Return on equity %-8.3-10.5 79.3%  
Return on capital %-6.4-0.8 850.6%  
Exports to sales %69.746.7 149.4%   
Imports to sales %12.40-   
Exports (fob) Rs m9,36617,213 54.4%   
Imports (cif) Rs m1,669NA-   
Fx inflow Rs m9,36618,113 51.7%   
Fx outflow Rs m1,669672 248.5%   
Net fx Rs m7,69717,442 44.1%   
CASH FLOW
From Operations Rs m-851444 -191.6%  
From Investments Rs m2,0283,025 67.1%  
From Financial Activity Rs m-813-2,139 38.0%  
Net Cashflow Rs m7461,328 56.2%  

Share Holding

Indian Promoters % 70.2 27.4 256.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.3 38.9 29.1%  
FIIs % 0.8 19.5 4.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.8 72.6 41.0%  
Shareholders   20,877 91,182 22.9%  
Pledged promoter(s) holding % 0.0 69.2 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Unichem Lab vs STRIDES PHARMA SCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Unichem Lab vs STRIDES PHARMA SCIENCE Share Price Performance

Period Unichem Lab STRIDES PHARMA SCIENCE S&P BSE HEALTHCARE
1-Day 1.90% 1.16% 1.18%
1-Month -5.40% 0.35% -0.75%
1-Year 78.12% 176.88% 61.82%
3-Year CAGR 16.06% -3.35% 18.16%
5-Year CAGR 19.87% 10.98% 19.79%

* Compound Annual Growth Rate

Here are more details on the Unichem Lab share price and the STRIDES PHARMA SCIENCE share price.

Moving on to shareholding structures...

The promoters of Unichem Lab hold a 70.2% stake in the company. In case of STRIDES PHARMA SCIENCE the stake stands at 27.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Unichem Lab and the shareholding pattern of STRIDES PHARMA SCIENCE.

Finally, a word on dividends...

In the most recent financial year, Unichem Lab paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

STRIDES PHARMA SCIENCE paid Rs 1.5, and its dividend payout ratio stood at -5.9%.

You may visit here to review the dividend history of Unichem Lab, and the dividend history of STRIDES PHARMA SCIENCE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.